Results 21 to 30 of about 5,025 (229)

A Retrospective Study of Chemotherapy-Related Extravasation Events in Dogs and Cats. [PDF]

open access: yesJ Vet Intern Med
ABSTRACT Background Chemotherapy extravasation is a potentially serious complication. There is a paucity of information in the veterinary literature investigating extravasation events, treatments, and outcomes. Objective Evaluate chemotherapy extravasation events and treatments in dogs and cats, adverse events (AEs), and overall outcomes.
Martens E   +12 more
europepmc   +2 more sources

Experimental bronchial arterial infusion of mechlorethamine

open access: bronzeThe Journal of Thoracic and Cardiovascular Surgery, 1965
James B.D. Mark   +2 more
openaire   +4 more sources

Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data

open access: yesDrug Design, Development and Therapy, 2018
Kendall Liner,1 Celeste Brown,2 Laura Y McGirt3 1Division of Dermatology, Medical College of Georgia at Augusta Health, Augusta, GA, USA; 2School of Medicine, University of North Carolina at Chapel Hill, Carolinas Medical Center, Charlotte, NC, USA ...
Liner K, Brown C, McGirt LY
doaj   +2 more sources

Ointment-based mechlorethamine treatment for mycosis fungoides [PDF]

open access: bronzeCancer, 1983
The treatment of skin disease with topical mechlorethamine has been restricted because of the frequent development of contact dermatitis. A series of 43 patients with mycosis fungoides in Stages 1A (17), IB (22), II (2), and III (2) were treated with an ointment-based mechlorethamine, prepared by an anhydrous method.
Norman M. Price   +2 more
openaire   +4 more sources

Jak-STAT Inhibition Mediates Romidepsin and Mechlorethamine Synergism in Cutaneous T-Cell Lymphoma

open access: greenJournal of Investigative Dermatology, 2021
José R. Cortés   +12 more
openalex   +3 more sources

Synergistic antiproliferative effect of mechlorethamine and amyloid beta-peptide on the human lung cancer cell line H441

open access: goldCancer Biology & Treatmen, 2021
Mechlorethamine (ME) is an antineoplastic agent which has been in clinical use for more than six decades. ME therapy is associated with high toxicity, and it is often in combination with other therapeutics.
Georgi L. Lukov, Theresa Tuthill
openalex   +2 more sources

Sulfur Mustard Analog Mechlorethamine (Bis(2-chloroethyl)methylamine) Modulates Cell Cycle Progression via the DNA Damage Response in Human Lung Epithelial A549 Cells [PDF]

open access: greenChemical Research in Toxicology, 2019
Nitrogen mustard, mechlorethamine (bis(2-chloroethyl)methylamine; HN2), and sulfur mustard are potent vesicants that modify and disrupt cellular macromolecules including DNA leading to cytotoxicity and tissue injury.
Yi‐Hua Jan   +3 more
openalex   +2 more sources

Topical Mechlorethamine for the Treatment of Psoriasis: A Report of Two Cases and Literature Review. [PDF]

open access: yesDermatol Ther (Heidelb), 2023
Introduction Psoriasis is a common inflammatory skin disease that significantly impacts patients’ psychosocial wellbeing. Despite increasingly effective treatment options, the recurrence of plaques after discontinuation of therapy in many patients ...
Fahmy LM   +4 more
europepmc   +2 more sources

Mechlorethamine Hydrochloride Gel [PDF]

open access: hybridDefinitions, 2020
A gel formulation composed of the hydrochloride salt form of mechlorethamine, which is a nitrogen mustard alkylating agent and an analog of sulfur mustard, with antineoplastic and immunosuppressive activities. Upon topical application, mechlorethamine is

openalex   +2 more sources

Home - About - Disclaimer - Privacy